Public Resources

A group of National Alliance expert advisors collaborated to produce “Opportunities in Pharmacy Benefit Management.” Included is information about:

• Taking advantage of the Consolidated Appropriations Act
• Understanding how PBMs are assigning value to the drugs employers are paying for
• Dealing with high-cost drugs that disproportionately drive healthcare spend
• Getting in front of the new astronomically priced gene therapies
• Maximizing competitive pressure biosimilars can exert on pricing
• Managing the disruption that comes with changing vendors or even formularies
• Understanding the role PBMS should play in managing the mental health and health equity crises